LymphedemaV1, PubMed, Curation, bibRecord, 002B57

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.

Identifieur interne : 002B57 ( PubMed/Curation ); précédent : 002B56; suivant : 002B58

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.

Auteurs : Jane M. Armer [États-Unis] ; Bob R. Stewart ; Robin P. Shook

Source :

Journal of lymphoedema [ 1750-7235 ] ; 2009.

RBID : pubmed:20182653

Abstract

BACKGROUND: Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer. AIMS: This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques. METHODS: Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met. RESULTS: Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41-91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest. CONCLUSIONS: This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).

PubMed: 20182653

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B57

Links to Exploration step

pubmed:20182653

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.</title>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<affiliation wicri:level="1"><nlm:affiliation>Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
</author>
<author><name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:20182653</idno>
<idno type="pmid">20182653</idno>
<idno type="wicri:Area/PubMed/Corpus">002B57</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B57</idno>
<idno type="wicri:Area/PubMed/Curation">002B57</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B57</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.</title>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name>
<affiliation wicri:level="1"><nlm:affiliation>Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name>
</author>
<author><name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name>
</author>
</analytic>
<series><title level="j">Journal of lymphoedema</title>
<idno type="ISSN">1750-7235</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer. AIMS: This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques. METHODS: Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met. RESULTS: Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41-91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest. CONCLUSIONS: This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">20182653</PMID>
<DateCreated><Year>2011</Year>
<Month>05</Month>
<Day>06</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1750-7235</ISSN>
<JournalIssue CitedMedium="Print"><Volume>4</Volume>
<Issue>1</Issue>
<PubDate><Year>2009</Year>
<Month>Apr</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Journal of lymphoedema</Title>
<ISOAbbreviation>J Lymphoedema</ISOAbbreviation>
</Journal>
<ArticleTitle>30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.</ArticleTitle>
<Pagination><MedlinePgn>14-18</MedlinePgn>
</Pagination>
<Abstract><AbstractText>BACKGROUND: Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer. AIMS: This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques. METHODS: Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met. RESULTS: Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41-91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest. CONCLUSIONS: This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Armer</LastName>
<ForeName>Jane M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>Bob R</ForeName>
<Initials>BR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Shook</LastName>
<ForeName>Robin P</ForeName>
<Initials>RP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>R01 NR005342</GrantID>
<Acronym>NR</Acronym>
<Agency>NINR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 NR005342-01A1</GrantID>
<Acronym>NR</Acronym>
<Agency>NINR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Scotland</Country>
<MedlineTA>J Lymphoedema</MedlineTA>
<NlmUniqueID>101466528</NlmUniqueID>
<ISSNLinking>1750-7235</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource>
<PMID Version="1">9874397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2798-802</RefSource>
<PMID Version="1">9874400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Nov 10;26(32):5213-9</RefSource>
<PMID Version="1">18838709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource>
<PMID Version="1">16379589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2004 Jan;187(1):69-72</RefSource>
<PMID Version="1">14706589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource>
<PMID Version="1">14639083</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2005;23(1):76-83</RefSource>
<PMID Version="1">15779870</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1209-15</RefSource>
<PMID Version="1">12654429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2817-20</RefSource>
<PMID Version="1">9874404</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Womens Health (Larchmt). 2003 Nov;12(9):921-30</RefSource>
<PMID Version="1">14670172</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Patient Educ Couns. 2006 Apr;61(1):72-9</RefSource>
<PMID Version="1">16533679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):383-91</RefSource>
<PMID Version="1">18297429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Clin Oncol. 2003 Jun;26(3):229-31</RefSource>
<PMID Version="1">12796589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2008 Mar;41(1):18-28</RefSource>
<PMID Version="1">18581955</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 2003 Jan;90(1):76-81</RefSource>
<PMID Version="1">12520579</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2788-97</RefSource>
<PMID Version="1">9874399</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2882-5</RefSource>
<PMID Version="1">9874417</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2004 Jan-Feb;31(1):97-104</RefSource>
<PMID Version="1">14722593</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20182653</ArticleId>
<ArticleId IdType="pmc">PMC2826842</ArticleId>
<ArticleId IdType="mid">NIHMS132326</ArticleId>
</ArticleIdList>
<pmc-dir>nihms</pmc-dir>
    </PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B57 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002B57 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:20182653
   |texte=   30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:20182653" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.

30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki